Mitsubishi Tanabe Pharma issues its news to provide stakeholders with the latest information related to the Company. Information on products or drug candidates may be included, but is intended to provide for the media, etc. It is not intended for promotion, advertising or medical advice. Information is current as of the date of issue of the individual news. Please be advised that information may be outdated after that point.
Information Notice Concerning the Transfer of Mitsubishi Tanabe Pharma Corporation and its Subsidiaries
February 7, 2025
The parent company of Mitsubishi Tanabe Pharma Corporation (Head Office: Osaka, Japan; Representative Director: Akihiro Tsujimura), Mitsubishi Chemical Group Corporation (Head office: Chiyoda-ku, Tokyo; President: Manabu Chikumoto) made the following announcement today.
Notice Concerning the Transfer of Mitsubishi Tanabe Pharma Corporation and its Subsidiaries
URL:https://www.mcgc.com/english/ir/pdf/02203/02496.pdf